Advancing precision oncology in breast cancer: the FDA approval of elacestrant and Guardant360 CDx: a correspondence.
Haleema Qayyum AbbasiAdeena MaryyumAbdul Moiz KhanSyeda ShahnoorMalik Olatunde OduoyeWechuli Polyne NafulaPublished in: International journal of surgery (London, England) (2023)